Core Laboratories Q2 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $124.609M Miss $125.100M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 42.11 percent decrease over earnings of $0.19 per share from the
Core Laboratories made more profit per share than experts predicted, which is good, but their total sales came in slightly lower than expected. When a company beats on profit but misses on sales, it means they're being careful with costs, but watch to see if they can grow their business bigger.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.